Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.
about
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancerIn Vivo Noninvasive Imaging for Gene TherapyRecovery of NIS expression in thyroid cancer cells by overexpression of Pax8 geneThe sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapiesThe use of the NIS reporter gene for optimizing oncolytic virotherapyHEX expression and localization in normal mammary gland and breast carcinomaTotal Thyroidectomy in the Mouse: the Feasibility Study in the Non-thyroidal Tumor Model Expressing Human Sodium/Iodide Symporter Gene.The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.Significance of Salivary Gland Radioiodine Retention on Post-ablation (131)I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid CarcinomaBaculovirus vector-mediated transfer of NIS gene into colon tumor cells for radionuclide therapy.Novel approaches in anaplastic thyroid cancer therapyThe sodium iodide symporter and thyroid disease.Objective assessment of image quality VI: imaging in radiation therapy.Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene deliveryGene therapy for thyroid cancer.Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and backAnaplastic giant cell thyroid carcinoma.Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene.The biology of the sodium iodide symporter and its potential for targeted gene delivery.Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer.Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.The correlation between breast cancer and urinary iodine excretion levels.[The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
P2860
Q24611278-86DE5FF9-AEFC-4536-89AC-4855CB0E06F7Q24790997-AAA702D1-AD7C-4C9B-BF55-23C6D4BF7C8CQ24814886-497F810F-1FA8-4560-A669-77E0C462B066Q27023157-A6F03DF3-EA50-42E3-B740-8DFD256E3073Q28083534-0A518535-0F1F-4061-B0F7-CECB96921531Q28504757-C3ED3B83-25C9-4421-87F5-97E335C5A081Q33704447-8216866A-9385-44DD-BC85-94232A61C9F0Q33776640-B163559A-8D51-49CB-B7C1-613216D55E56Q33947642-28873B23-9D25-4A39-8539-E93EB3FD67DFQ34090852-DBE9AFFA-9A03-4D43-90CD-F2E919258966Q34306787-2DF220F2-6E64-4A69-A1DD-65BB775A21A8Q34458018-CCC2B46E-9A5C-419A-BBEB-BEF5D2021F18Q34609548-4092BDD5-3D56-4818-A398-DEC5D7800E3DQ35077729-1B7C7F38-D81C-47C9-963D-948A4C60FA45Q35575677-AC35EEA6-68F4-4E23-9A69-DFA0B3F4E5D1Q35842601-AA19877B-7B8E-4A42-8D2E-E2F4D1660AC6Q35915781-5BC5F97C-13BC-4C85-A205-EC45DBAFE84CQ36013613-2BC08DA3-31FD-41BB-91B1-C084C722F0C0Q36046238-FECB8C15-E215-4CA7-A356-CDAA2E67123EQ36499907-7B204CB5-FE70-48FC-91FE-8B91F2801EE4Q37262334-7BC59A5A-B319-4B61-8B39-2DD77045487CQ37564872-5DC4060B-9041-4FB2-8A9C-D19730D74933Q37691930-3955140F-096B-4031-B91B-89C624CEA3C7Q38772380-4A369F08-8B80-4625-A31E-6D09EC160D00Q38772797-D99BE1F7-52AD-4EA4-9216-8C1C81B99B01Q38823954-A7073328-6A77-4CA3-B17C-81ED9D5556E2Q40498934-ACE4F8F8-2499-43EF-B228-C363321F6637Q45883444-86060075-8D34-4C57-8682-9BD03E9E83ACQ50252211-4F154886-9711-40A1-8225-D854942A0715Q53856147-BDD15B8E-CFBA-4671-876F-BEDE64CB0D41
P2860
Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@ast
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@en
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@nl
type
label
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@ast
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@en
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@nl
prefLabel
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@ast
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@en
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@nl
P2093
P356
P1476
Clinical review 132: The sodiu ...... ential role in cancer therapy.
@en
P2093
P304
P356
10.1210/JCEM.86.7.7641
P407
P577
2001-07-01T00:00:00Z